Europe Genital Herpes Treatment Market 2022-2032 by Virus Type (HSV-1, HSV-2), Drug Type (Acyclovir, Valacyclovir, Famciclovir, Others), Route of Administration (Oral, Topical, Injection), Patient Gender (Female, Male), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Drug Stores), and Country: Trend Forecast and Growth Opportunity
Europe genital herpes treatment market was valued at $958.5 million in 2022 and will grow by 4.1% annually over 2022-2032, driven by the rising prevalence of sexually transmitted diseases, changing socio-cultural openness, increasing awareness about HSV infection and its symptoms, improved access to antiviral medications, and the government supports.
Highlighted with 35 tables and 45 figures, this 111-page report “Europe Genital Herpes Treatment Market 2022-2032 by Virus Type (HSV-1, HSV-2), Drug Type (Acyclovir, Valacyclovir, Famciclovir, Others), Route of Administration (Oral, Topical, Injection), Patient Gender (Female, Male), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Drug Stores), and Country: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire Europe genital herpes treatment market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2021-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
Market Structure
Growth Drivers
Restraints and Challenges
Emerging Product Trends & Market Opportunities
Porter’s Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Europe genital herpes treatment market in every aspect of the classification from perspectives Virus, Drug Type, Route of Administration, Patient Gender, Distribution Channel, and Country.
Based on Virus Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
HSV-1
HSV-2
Based on Drug Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
Acyclovir
Valacyclovir
Famciclovir
Other Drugs
By Route of Administration, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
Oral
Topical
Injection
By Patient Gender, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
Female
Male
By Distribution Channel, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Drug Stores
Geographically, the following national/local markets are fully investigated:
Germany
UK
France
Spain
Italy
Netherlands
Rest of Europe (further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2032. The breakdown of national markets by Virus Type, Drug Type and Distribution Channel over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott
ADLEY FORMULATIONS
Aurobindo Pharma Ltd.
Avet Pharmaceuticals Inc.
Bausch Health Companies
Centurion Remedies
Cipla Ltd.
Eli Lilly & Company
Finecure Pharmaceuticals
GlaxoSmithKline Plc
Glenmark Pharmaceuticals
Macleods Pharmaceuticals
Medico Remedies
Merck & Co., Inc.
Novartis AG
Pfizer
Reddy's Laboratories
Sanofi SA
Teva Pharmaceutical Industries Ltd.
Torrent Pharma
Viatris Inc.
Zeelab Pharmacy
Zydus Pharmaceuticals, Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Highlighted with 35 tables and 45 figures, this 111-page report “Europe Genital Herpes Treatment Market 2022-2032 by Virus Type (HSV-1, HSV-2), Drug Type (Acyclovir, Valacyclovir, Famciclovir, Others), Route of Administration (Oral, Topical, Injection), Patient Gender (Female, Male), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Drug Stores), and Country: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire Europe genital herpes treatment market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2021-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
Market Structure
Growth Drivers
Restraints and Challenges
Emerging Product Trends & Market Opportunities
Porter’s Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Europe genital herpes treatment market in every aspect of the classification from perspectives Virus, Drug Type, Route of Administration, Patient Gender, Distribution Channel, and Country.
Based on Virus Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
HSV-1
HSV-2
Based on Drug Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
Acyclovir
Valacyclovir
Famciclovir
Other Drugs
By Route of Administration, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
Oral
Topical
Injection
By Patient Gender, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
Female
Male
By Distribution Channel, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Drug Stores
Geographically, the following national/local markets are fully investigated:
Germany
UK
France
Spain
Italy
Netherlands
Rest of Europe (further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2032. The breakdown of national markets by Virus Type, Drug Type and Distribution Channel over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott
ADLEY FORMULATIONS
Aurobindo Pharma Ltd.
Avet Pharmaceuticals Inc.
Bausch Health Companies
Centurion Remedies
Cipla Ltd.
Eli Lilly & Company
Finecure Pharmaceuticals
GlaxoSmithKline Plc
Glenmark Pharmaceuticals
Macleods Pharmaceuticals
Medico Remedies
Merck & Co., Inc.
Novartis AG
Pfizer
Reddy's Laboratories
Sanofi SA
Teva Pharmaceutical Industries Ltd.
Torrent Pharma
Viatris Inc.
Zeelab Pharmacy
Zydus Pharmaceuticals, Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 INTRODUCTION
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary
2 MARKET OVERVIEW AND DYNAMICS
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis
3 SEGMENTATION OF EUROPE MARKET BY VIRUS TYPE
3.1 Market Overview by Virus Type
3.2 HSV-1
3.3 HSV-2
4 SEGMENTATION OF EUROPE MARKET BY DRUG TYPE
4.1 Market Overview by Drug Type
4.2 Acyclovir
4.3 Valacyclovir
4.4 Famciclovir
4.5 Other Drugs
5 SEGMENTATION OF EUROPE MARKET BY ROUTE OF ADMINISTRATION
5.1 Market Overview by Route of Administration
5.2 Oral
5.3 Topical
5.4 Injection
6 SEGMENTATION OF EUROPE MARKET BY PATIENT GENDER
6.1 Market Overview by Patient Gender
6.2 Female
6.3 Male
7 SEGMENTATION OF EUROPE MARKET BY DISTRIBUTION CHANNEL
7.1 Market Overview by Distribution Channel
7.2 Retail Pharmacies
7.3 Hospital Pharmacies
7.4 Online Pharmacies
7.5 Drug Stores
8 EUROPEAN MARKET 2022-2032 BY COUNTRY
8.1 Overview of European Market
8.2 Germany
8.3 U.K.
8.4 France
8.5 Spain
8.6 Italy
8.7 Netherlands
8.8 Rest of European Market
9 COMPETITIVE LANDSCAPE
9.1 Overview of Key Vendors
9.2 New Product Launch, Partnership, Investment, and M&A
9.3 Company Profiles
Abbott
ADLEY FORMULATIONS
Aurobindo Pharma Ltd.
Avet Pharmaceuticals Inc.
Bausch Health Companies
Centurion Remedies
Cipla Ltd.
Eli Lilly & Company
Finecure Pharmaceuticals
GlaxoSmithKline Plc
Glenmark Pharmaceuticals
Macleods Pharmaceuticals
Medico Remedies
Merck & Co., Inc.
Novartis AG
Pfizer
Reddy's Laboratories
Sanofi SA
Teva Pharmaceutical Industries Ltd.
Torrent Pharma
Viatris Inc.
Zeelab Pharmacy
Zydus Pharmaceuticals, Inc.
RELATED REPORTS
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary
2 MARKET OVERVIEW AND DYNAMICS
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis
3 SEGMENTATION OF EUROPE MARKET BY VIRUS TYPE
3.1 Market Overview by Virus Type
3.2 HSV-1
3.3 HSV-2
4 SEGMENTATION OF EUROPE MARKET BY DRUG TYPE
4.1 Market Overview by Drug Type
4.2 Acyclovir
4.3 Valacyclovir
4.4 Famciclovir
4.5 Other Drugs
5 SEGMENTATION OF EUROPE MARKET BY ROUTE OF ADMINISTRATION
5.1 Market Overview by Route of Administration
5.2 Oral
5.3 Topical
5.4 Injection
6 SEGMENTATION OF EUROPE MARKET BY PATIENT GENDER
6.1 Market Overview by Patient Gender
6.2 Female
6.3 Male
7 SEGMENTATION OF EUROPE MARKET BY DISTRIBUTION CHANNEL
7.1 Market Overview by Distribution Channel
7.2 Retail Pharmacies
7.3 Hospital Pharmacies
7.4 Online Pharmacies
7.5 Drug Stores
8 EUROPEAN MARKET 2022-2032 BY COUNTRY
8.1 Overview of European Market
8.2 Germany
8.3 U.K.
8.4 France
8.5 Spain
8.6 Italy
8.7 Netherlands
8.8 Rest of European Market
9 COMPETITIVE LANDSCAPE
9.1 Overview of Key Vendors
9.2 New Product Launch, Partnership, Investment, and M&A
9.3 Company Profiles
Abbott
ADLEY FORMULATIONS
Aurobindo Pharma Ltd.
Avet Pharmaceuticals Inc.
Bausch Health Companies
Centurion Remedies
Cipla Ltd.
Eli Lilly & Company
Finecure Pharmaceuticals
GlaxoSmithKline Plc
Glenmark Pharmaceuticals
Macleods Pharmaceuticals
Medico Remedies
Merck & Co., Inc.
Novartis AG
Pfizer
Reddy's Laboratories
Sanofi SA
Teva Pharmaceutical Industries Ltd.
Torrent Pharma
Viatris Inc.
Zeelab Pharmacy
Zydus Pharmaceuticals, Inc.
RELATED REPORTS
LIST OF TABLES:
Table 1. Snapshot of Europe Genital Herpes Treatment Market in Balanced Perspective, 2022-2032
Table 2. World Economic Outlook, 2021-2031
Table 3. World Economic Outlook, 2021-2023
Table 4. World Health Spending by Region, $ bn, 2013-2020
Table 5. Main Product Trends and Market Opportunities in Europe Genital Herpes Treatment Market
Table 6. Europe Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn
Table 7. Europe Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn
Table 8. Side Effects of Genital Herpes Medications
Table 9. Vaccine Pipelines for Herpes
Table 10. Europe Genital Herpes Treatment Market by Route of Administration, 2022-2032, $ mn
Table 11. Europe Genital Herpes Treatment Market by Patient Gender, 2022-2032, $ mn
Table 12. Europe Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn
Table 13. Europe Genital Herpes Treatment Market by Country, 2022-2032, $ mn
Table 14. Germany Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn
Table 15. Germany Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn
Table 16. Germany Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn
Table 17. U.K. Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn
Table 18. U.K. Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn
Table 19. U.K. Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn
Table 20. France Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn
Table 21. France Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn
Table 22. France Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn
Table 23. Spain Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn
Table 24. Spain Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn
Table 25. Spain Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn
Table 26. Italy Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn
Table 27. Italy Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn
Table 28. Italy Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn
Table 29. Netherlands Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn
Table 30. Netherlands Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn
Table 31. Netherlands Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn
Table 32. Genital Herpes Treatment Market in Rest of Europe by Country, 2022-2032, $ mn
Table 33. Abbott: Company Snapshot
Table 34. Abbott: Business Segmentation
Table 35. Abbott: Product Portfolio
Table 1. Snapshot of Europe Genital Herpes Treatment Market in Balanced Perspective, 2022-2032
Table 2. World Economic Outlook, 2021-2031
Table 3. World Economic Outlook, 2021-2023
Table 4. World Health Spending by Region, $ bn, 2013-2020
Table 5. Main Product Trends and Market Opportunities in Europe Genital Herpes Treatment Market
Table 6. Europe Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn
Table 7. Europe Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn
Table 8. Side Effects of Genital Herpes Medications
Table 9. Vaccine Pipelines for Herpes
Table 10. Europe Genital Herpes Treatment Market by Route of Administration, 2022-2032, $ mn
Table 11. Europe Genital Herpes Treatment Market by Patient Gender, 2022-2032, $ mn
Table 12. Europe Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn
Table 13. Europe Genital Herpes Treatment Market by Country, 2022-2032, $ mn
Table 14. Germany Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn
Table 15. Germany Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn
Table 16. Germany Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn
Table 17. U.K. Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn
Table 18. U.K. Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn
Table 19. U.K. Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn
Table 20. France Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn
Table 21. France Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn
Table 22. France Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn
Table 23. Spain Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn
Table 24. Spain Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn
Table 25. Spain Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn
Table 26. Italy Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn
Table 27. Italy Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn
Table 28. Italy Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn
Table 29. Netherlands Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn
Table 30. Netherlands Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn
Table 31. Netherlands Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn
Table 32. Genital Herpes Treatment Market in Rest of Europe by Country, 2022-2032, $ mn
Table 33. Abbott: Company Snapshot
Table 34. Abbott: Business Segmentation
Table 35. Abbott: Product Portfolio
LIST OF FIGURES:
Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2032
Figure 4. Europe Genital Herpes Treatment Market, 2022-2032, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of Europe Genital Herpes Treatment Market
Figure 7. Forecast of Middle-class Population by Region, 2015-2030, million
Figure 8. Primary Restraints and Impact Factors of Europe Genital Herpes Treatment Market
Figure 9. Investment Opportunity Analysis
Figure 10. Porter’s Fiver Forces Analysis of Europe Genital Herpes Treatment Market
Figure 11. Breakdown of Europe Genital Herpes Treatment Market by Virus Type, 2022-2032, % of Revenue
Figure 12. Europe Addressable Market Cap in 2023-2032 by Virus Type, Value ($ mn) and Share (%)
Figure 13. Europe Genital Herpes Treatment Market by Virus Type: HSV-1, 2022-2032, $ mn
Figure 14. Europe Genital Herpes Treatment Market by Virus Type: HSV-2, 2022-2032, $ mn
Figure 15. Breakdown of Europe Genital Herpes Treatment Market by Drug Type, 2022-2032, % of Sales Revenue
Figure 16. Europe Addressable Market Cap in 2023-2032 by Drug Type, Value ($ mn) and Share (%)
Figure 17. Europe Genital Herpes Treatment Market by Drug Type: Acyclovir, 2022-2032, $ mn
Figure 18. Europe Genital Herpes Treatment Market by Drug Type: Valacyclovir, 2022-2032, $ mn
Figure 19. Europe Genital Herpes Treatment Market by Drug Type: Famciclovir, 2022-2032, $ mn
Figure 20. Europe Genital Herpes Treatment Market by Drug Type: Other Drugs, 2022-2032, $ mn
Figure 21. Breakdown of Europe Genital Herpes Treatment Market by Route of Administration, 2022-2032, % of Sales Revenue
Figure 22. Europe Addressable Market Cap in 2023-2032 by Route of Administration, Value ($ mn) and Share (%)
Figure 23. Europe Genital Herpes Treatment Market by Route of Administration: Oral, 2022-2032, $ mn
Figure 24. Europe Genital Herpes Treatment Market by Route of Administration: Topical, 2022-2032, $ mn
Figure 25. Europe Genital Herpes Treatment Market by Route of Administration: Injection, 2022-2032, $ mn
Figure 26. Breakdown of Europe Genital Herpes Treatment Market by Patient Gender, 2022-2032, % of Revenue
Figure 27. Europe Addressable Market Cap in 2023-2032 by Patient Gender, Value ($ mn) and Share (%)
Figure 28. Europe Genital Herpes Treatment Market by Patient Gender: Female, 2022-2032, $ mn
Figure 29. Europe Genital Herpes Treatment Market by Patient Gender: Male, 2022-2032, $ mn
Figure 30. Breakdown of Europe Genital Herpes Treatment Market by Distribution Channel, 2022-2032, % of Revenue
Figure 31. Europe Addressable Market Cap in 2023-2032 by Distribution Channel, Value ($ mn) and Share (%)
Figure 32. Europe Genital Herpes Treatment Market by Distribution Channel: Retail Pharmacies, 2022-2032, $ mn
Figure 33. Europe Genital Herpes Treatment Market by Distribution Channel: Hospital Pharmacies, 2022-2032, $ mn
Figure 34. Europe Genital Herpes Treatment Market by Distribution Channel: Online Pharmacies, 2022-2032, $ mn
Figure 35. Europe Genital Herpes Treatment Market by Distribution Channel: Drug Stores, 2022-2032, $ mn
Figure 36. Breakdown of European Genital Herpes Treatment Market by Country, 2022 and 2032, % of Revenue
Figure 37. Contribution to Europe 2023-2032 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 38. Genital Herpes Treatment Market in Germany, 2022-2032, $ mn
Figure 39. Genital Herpes Treatment Market in U.K., 2022-2032, $ mn
Figure 40. Genital Herpes Treatment Market in France, 2022-2032, $ mn
Figure 41. Genital Herpes Treatment Market in Spain, 2022-2032, $ mn
Figure 42. Genital Herpes Treatment Market in Italy, 2022-2032, $ mn
Figure 43. Genital Herpes Treatment Market in Netherlands, 2022-2032, $ mn
Figure 44. Genital Herpes Treatment Market in Rest of Europe, 2022-2032, $ mn
Figure 45. Growth Stage of Europe Genital Herpes Treatment Industry over the Forecast Period
Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2032
Figure 4. Europe Genital Herpes Treatment Market, 2022-2032, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of Europe Genital Herpes Treatment Market
Figure 7. Forecast of Middle-class Population by Region, 2015-2030, million
Figure 8. Primary Restraints and Impact Factors of Europe Genital Herpes Treatment Market
Figure 9. Investment Opportunity Analysis
Figure 10. Porter’s Fiver Forces Analysis of Europe Genital Herpes Treatment Market
Figure 11. Breakdown of Europe Genital Herpes Treatment Market by Virus Type, 2022-2032, % of Revenue
Figure 12. Europe Addressable Market Cap in 2023-2032 by Virus Type, Value ($ mn) and Share (%)
Figure 13. Europe Genital Herpes Treatment Market by Virus Type: HSV-1, 2022-2032, $ mn
Figure 14. Europe Genital Herpes Treatment Market by Virus Type: HSV-2, 2022-2032, $ mn
Figure 15. Breakdown of Europe Genital Herpes Treatment Market by Drug Type, 2022-2032, % of Sales Revenue
Figure 16. Europe Addressable Market Cap in 2023-2032 by Drug Type, Value ($ mn) and Share (%)
Figure 17. Europe Genital Herpes Treatment Market by Drug Type: Acyclovir, 2022-2032, $ mn
Figure 18. Europe Genital Herpes Treatment Market by Drug Type: Valacyclovir, 2022-2032, $ mn
Figure 19. Europe Genital Herpes Treatment Market by Drug Type: Famciclovir, 2022-2032, $ mn
Figure 20. Europe Genital Herpes Treatment Market by Drug Type: Other Drugs, 2022-2032, $ mn
Figure 21. Breakdown of Europe Genital Herpes Treatment Market by Route of Administration, 2022-2032, % of Sales Revenue
Figure 22. Europe Addressable Market Cap in 2023-2032 by Route of Administration, Value ($ mn) and Share (%)
Figure 23. Europe Genital Herpes Treatment Market by Route of Administration: Oral, 2022-2032, $ mn
Figure 24. Europe Genital Herpes Treatment Market by Route of Administration: Topical, 2022-2032, $ mn
Figure 25. Europe Genital Herpes Treatment Market by Route of Administration: Injection, 2022-2032, $ mn
Figure 26. Breakdown of Europe Genital Herpes Treatment Market by Patient Gender, 2022-2032, % of Revenue
Figure 27. Europe Addressable Market Cap in 2023-2032 by Patient Gender, Value ($ mn) and Share (%)
Figure 28. Europe Genital Herpes Treatment Market by Patient Gender: Female, 2022-2032, $ mn
Figure 29. Europe Genital Herpes Treatment Market by Patient Gender: Male, 2022-2032, $ mn
Figure 30. Breakdown of Europe Genital Herpes Treatment Market by Distribution Channel, 2022-2032, % of Revenue
Figure 31. Europe Addressable Market Cap in 2023-2032 by Distribution Channel, Value ($ mn) and Share (%)
Figure 32. Europe Genital Herpes Treatment Market by Distribution Channel: Retail Pharmacies, 2022-2032, $ mn
Figure 33. Europe Genital Herpes Treatment Market by Distribution Channel: Hospital Pharmacies, 2022-2032, $ mn
Figure 34. Europe Genital Herpes Treatment Market by Distribution Channel: Online Pharmacies, 2022-2032, $ mn
Figure 35. Europe Genital Herpes Treatment Market by Distribution Channel: Drug Stores, 2022-2032, $ mn
Figure 36. Breakdown of European Genital Herpes Treatment Market by Country, 2022 and 2032, % of Revenue
Figure 37. Contribution to Europe 2023-2032 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 38. Genital Herpes Treatment Market in Germany, 2022-2032, $ mn
Figure 39. Genital Herpes Treatment Market in U.K., 2022-2032, $ mn
Figure 40. Genital Herpes Treatment Market in France, 2022-2032, $ mn
Figure 41. Genital Herpes Treatment Market in Spain, 2022-2032, $ mn
Figure 42. Genital Herpes Treatment Market in Italy, 2022-2032, $ mn
Figure 43. Genital Herpes Treatment Market in Netherlands, 2022-2032, $ mn
Figure 44. Genital Herpes Treatment Market in Rest of Europe, 2022-2032, $ mn
Figure 45. Growth Stage of Europe Genital Herpes Treatment Industry over the Forecast Period
